The fusion of mRNA technology with AI has laid the foundation for ushering in a new era of cancer care. However, conducting ...

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $428 million specializing in mRNA therapeutics and vaccines, stands at a ...

Chairman Larry Ellison highlighted the AI's potential in the development of mRNA-based cancer vaccines. Read more here.

The president announced a major AI investment project, which Oracle Chairman Larry Ellison said could be used to cure cancer.

As of market close on Friday, Jan. 24, Moderna stock is up 21.6% this week. Here's why.

The latest guidance reduction was the second time in the last six months that the firm has revised its forecast in a negative ...

The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...

A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...

Moderna's stock roared higher on the back of news about potential AI mRNA vaccines. The company also secured a supply contract in Europe. Shares of Moderna are down 90%, and the company has a huge ...

We're learning more about a massive artificial intelligence infrastructure bill announced Tuesday by President Donald Trump.

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.